Home › Fabry Disease › Alabama
Fabry Disease clinical trials in Alabama
5 studies for Fabry Disease are looking for participants at sites in Alabama.
Cities in Alabama
A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry Disease
- University of Alabama of Birmingham, Birmingham
RecruitingPhase 3
Ages 18 to 60 · Men · Updated Nov 3, 2026 · NCT07778667A Study of Patients With Fabry Disease (US Specific)
- UAB Nephrology Research Clinic at Paula Building, Birmingham
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT06906367Fabry Disease Registry & Pregnancy Sub-registry
- University Of Alabama Birmingham- Nephrology- Site Number : 840073, Birmingham
RecruitingObservational study
All ages · All sexes · Updated Oct 14, 2026 · NCT00196742Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
- The Kirklin Clinic Of University of Alabama Birmingham Hospital, Birmingham
RecruitingPhase 1/2
Ages 18 to 65 · Men · Updated Sep 24, 2026 · NCT06270316A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
- University of Alabama at Birmingham, Birmingham
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 14, 2025 · NCT06663358From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.